Neonatal Med.  2019 May;26(2):111-116. 10.5385/nm.2019.26.2.111.

Thyroid Hormone Resistance in a Preterm Infant with a Novel THRB Mutation

Affiliations
  • 1Department of Pediatrics, Konyang University College of Medicine, Daejeon, Korea. jwlim@kyuh.ac.kr
  • 2Department of Pediatrics, Chungnam National University College of Medicine, Daejeon, Korea.
  • 3Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Abstract

Resistance to thyroid hormone (RTH) is a condition caused by a mutation in the thyroid hormone receptor gene. It is rarely reported in individuals with no family history of RTH or in premature infants, and its clinical presentation varies. In our case, a premature infant with no family history of thyroid diseases had a thyroid stimulating hormone level of 85.0 µIU/mL and free thyroxine level of 1.64 ng/dL on a thyroid function test. The patient also presented with clinical signs of hypothyroidism, including difficulties in feeding and weight gain. The patient was treated with levothyroxine; however, only free thyroxine and triiodothyronine levels increased without a decrease in thyroid-stimulating hormone levels. Taken together with thyroid gland hypertrophy observed on a previous ultrasound examination, RTH was suspected and the diagnosis was eventually made based on a genetic test. A de novo mutation in the thyroid hormone receptor β gene in the infant was found that has not been previously reported. Other symptoms included tachycardia and pulmonary hypertension, but gradual improvement in the symptoms was observed after liothyronine administration. This report describes a case involving a premature infant with RTH and a de novo mutation, with no family history of thyroid disease.

Keyword

Thyroid hormone resistance syndrome; Infant, premature; Thyroid hormone receptors beta; Goiter; Triiodothyronine

MeSH Terms

Diagnosis
Goiter
Humans
Hypertension, Pulmonary
Hypertrophy
Hypothyroidism
Infant
Infant, Newborn
Infant, Premature*
Receptors, Thyroid Hormone
Tachycardia
Thyroid Diseases
Thyroid Function Tests
Thyroid Gland*
Thyroid Hormone Receptors beta
Thyroid Hormone Resistance Syndrome*
Thyrotropin
Thyroxine
Triiodothyronine
Ultrasonography
Weight Gain
Receptors, Thyroid Hormone
Thyroid Hormone Receptors beta
Thyrotropin
Thyroxine
Triiodothyronine

Figure

  • Figure 1. Thyroid ultrasonography. Hypertrophy of both thyroid glands (2.3×4.3 cm).

  • Figure 2. Technetium-99m thyroid scan showing homogeneously enlarged thyroid glands with markedly increased activity.

  • Figure 3. Direct sequencing of thyroid hormone receptor beta (THRB) in the patient. A heterozygous mutation (NM_000461.4:c. 1320delG(p.His441Thrfs*2)) was identified in the patient.


Reference

1. Olateju TO, Vanderpump MP. Thyroid hormone resistance. Ann Clin Biochem. 2006; 43(Pt 6):431–40.
2. Dumitrescu AM, Refetoff S. The syndromes of reduced sensitivity to thyroid hormone. Biochim Biophys Acta. 2013; 1830:3987–4003.
3. Lee JH, Kim EY. Resistance to thyroid hormone due to a novel mutation of thyroid hormone receptor beta gene. Ann Pediatr Endocrinol Metab. 2014; 19:229–31.
4. Bochukova E, Schoenmakers N, Agostini M, Schoenmakers E, Rajanayagam O, Keogh JM, et al. A mutation in the thyroid hormone receptor alpha gene. N Engl J Med. 2012; 366:243–9.
5. Usala SJ, Bale AE, Gesundheit N, Weinberger C, Lash RW, Wondisford FE, et al. Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene. Mol Endocrinol. 1988; 2:1217–20.
6. Chatterjee VK, Gurnell M. Thyroid hormone resistance syndrome. In : Gale EAM, Wass JAH, Shalet SM, editors. Oxford textbook of endocrinology. London: Oxford University Press;2002. p. 339–49.
7. Yatsuga S, Hiromatsu Y, Sasaki S, Nakamura H, Katayama K, Nishioka J, et al. A two-day-old hyperthyroid neonate with thyroid hormone resistance born to a mother with well-conrolled Graves' disease: a case report. J Med Case Rep. 2012; 6:246.
8. Sambalingam D, Jyotsna Rao K. Neonatal "resistance to thyroid hormone (refetoff syndrome)" with novel THRB mutation. J Clin Neonatol. 2017; 6:273–5.
9. Refetoff S, Dumitrescu AM. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab. 2007; 21:277–305.
10. Pohlenz J, Weiss RE, Macchia PE, Pannain S, Lau IT, Ho H, et al. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. J Clin Endocrinol Metab. 1999; 84:3919–28.
11. Weiss RE, Weinberg M, Refetoff S. Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families. J Clin Invest. 1993; 91:2408–15.
12. Kim JH, Park TS, Baek HS, Kim GH, Yoo HW, Park JH. A newly identified insertion mutation in the thyroid hormone receptor-beta gene in a Korean family with generalized thyroid hormone resistance. J Korean Med Sci. 2007; 22:560–3.
13. Asteria C, Rajanayagam O, Collingwood TN, Persani L, Romoli R, Mannavola D, et al. Prenatal diagnosis of thyroid hormone resistance. J Clin Endocrinol Metab. 1999; 84:405–10.
14. Weiss RE, Dumitrescu A, Refetoff S. Approach to the patient with resistance to thyroid hormone and pregnancy. J Clin Endocrinol Metab. 2010; 95:3094–102.
15. Rivas AM, Lado-Abeal J. Thyroid hormone resistance and its management. Proc (Bayl Univ Med Cent). 2016; 29:209–11.
16. Brucker-Davis F, Skarulis MC, Pikus A, Ishizawar D, Mastroianni MA, Koby M, et al. Prevalence and mechanisms of hearing loss in patients with resistance to thyroid hormone. J Clin Endocrinol Metab. 1996; 81:2768–72.
17. Zuhur SS, Baykiz D, Kara SP, Sahin E, Kuzu I, Elbuken G. Relationship among pulmonary hypertension, autoimmunity, thyroid hormones and dyspnea in patients with hyperthyroidism. Am J Med Sci. 2017; 353:374–80.
18. Weiss RE, Refetoff S. Treatment of resistance to thyroid hormone: primum non nocere. J Clin Endocrinol Metab. 1999; 84:401–4.
19. Maruo Y, Mori A, Morioka Y, Sawai C, Mimura Y, Matui K, et al. Successful every-other-day liothyronine therapy for severe resistance to thyroid hormone beta with a novel THRB mutation; case report. BMC Endocr Disord. 2016; 16:1.
20. Dorey F, Strauch G, Gayno JP. Thyrotoxicosis due to pituitary resistance to thyroid hormones. Successful control with D thyroxine: a study in three patients. Clin Endocrinol (Oxf). 1990; 32:221–8.
Full Text Links
  • NM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr